Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
115 hedge funds and large institutions have $74.7M invested in Sanofi Contingent Value Rights in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 7 closing their positions.
14% more capital inflows, than outflows
Capital inflows: $8.23M | Capital outflows: $7.21M
2% less funds holding
Funds holding: 117 → 115 (-2)
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Elliott Management
New York
|
+$6.02M |
| 2 |
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.05M |
| 3 |
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$699K |
| 4 |
LCM
Lonestar Capital Management
San Francisco,
California
|
+$365K |
| 5 |
JP Morgan Chase
New York
|
+$34.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Whitebox Advisors
Minneapolis,
Minnesota
|
-$5.92M |
| 2 |
Pomelo Capital
New York
|
-$559K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$260K |
| 4 |
Millennium Management
New York
|
-$163K |
| 5 |
GAMCO Investors
Greenwich,
Connecticut
|
-$73.4K |
GCVRZ Hedge Fund Activity: Q1 2015 in Review
115 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2015, worth a combined $74.7M — down 12% from $85.2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of GCVRZ and 4 opened new positions — a net loss of 3 holders — while 19 trimmed existing stakes and 14 added.
The largest buyer was Elliott Management, opening a new position worth an estimated $6.02M. The largest seller was Whitebox Advisors, cutting an estimated $5.92M.
- 115 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2015, down from 117 in Q4 2014.
- Funds reported $74.7M of Sanofi Contingent Value Rights stock for Q1 2015, down 12% quarter-over-quarter.
- 4 funds opened new Sanofi Contingent Value Rights positions in Q1 2015 and 7 closed out, a net change of -3 holders.
- The largest Sanofi Contingent Value Rights buyer in Q1 2015 was Elliott Management, an estimated $6.02M added.
- The largest Sanofi Contingent Value Rights seller in Q1 2015 was Whitebox Advisors, an estimated $5.92M sold.
Based on aggregated 13F filings for Q1 2015.